Healthcare

The American healthcare giant UnitedHealth is implementing a dramatic strategic reversal that will result in hundreds of thousands of customers...

Cellectar Biosciences is attracting significant market attention following the release of encouraging interim data from its CLOVER-2 Phase 1b study....

After nearly a century as a publicly traded company, Walgreens Boots Alliance has officially departed from public markets. On August...

MediaAlpha finds itself navigating turbulent waters as its business units chart dramatically different courses. The advertising technology specialist reported second...

Danaher Corporation is making significant strides in artificial intelligence integration across its life sciences portfolio, earning market approval for its...

Bristol-Myers Squibb has secured a significant regulatory achievement with the FDA granting Fast-Track status to its Alzheimer's disease candidate, BMS-986446....

Medical technology giant Becton Dickinson enters October with notable momentum, propelled by multiple strategic developments that could signal a potential...

Biogen has achieved significant regulatory and clinical milestones for its Alzheimer's treatment Leqembi, positioning the biotechnology firm for potential growth...

The neuroscience sector appears poised for significant transformation, and Axsome Therapeutics is emerging as a potential standout performer. With its...

The American healthcare behemoth UnitedHealth is implementing significant coverage reductions that impact hundreds of thousands of customers, yet investor response...